Clinical Trials Insight: 700057341

Trial Profile

Clinical Trials Insight: 700057341

Phase of Trial: Phase I

Latest Information Update: 24 Jun 2010

At a glance

  • Drugs B7-2 GM-CSF cancer gene therapy (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Radient Pharmaceuticals Corporation
  • Most Recent Events

    • 24 Jun 2010 Results have been reported in a Radient Pharmaceuticals media release.
    • 24 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top